These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 23877678)

  • 1. Effect of pulmonary surfactant on antimicrobial activity in vitro.
    Schwameis R; Erdogan-Yildirim Z; Manafi M; Zeitlinger MA; Strommer S; Sauermann R
    Antimicrob Agents Chemother; 2013 Oct; 57(10):5151-4. PubMed ID: 23877678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Enterococcus faecalis on the bactericidal activities of arbekacin, daptomycin, linezolid, and tigecycline against methicillin-resistant Staphylococcus aureus in a mixed-pathogen pharmacodynamic model.
    LaPlante KL; Rybak MJ; Leuthner KD; Chin JN
    Antimicrob Agents Chemother; 2006 Apr; 50(4):1298-303. PubMed ID: 16569844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recently introduced antibiotics: a guide for the general physician.
    Wiselka M
    Clin Med (Lond); 2004; 4(6):494-8. PubMed ID: 15656473
    [No Abstract]   [Full Text] [Related]  

  • 4. Ciprofloxacin- and methicillin-resistant staphylococcus aureus susceptible to moxifloxacin, levofloxacin, teicoplanin, vancomycin and linezolid.
    Presterl E; Mueller-Uri P; Grisold A; Georgopoulos A; Graninger W
    Eur J Clin Microbiol Infect Dis; 2001 Jul; 20(7):486-9. PubMed ID: 11561805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [In vitro activity of linezolid, moxifloxacin, levofloxacin, clindamycin and rifampin, alone and in combination, against Staphylococcus aureus and Staphylococcus epidermidis].
    Soriano A; Jurado A; Marco F; Almela M; Ortega M; Mensa J
    Rev Esp Quimioter; 2005 Jun; 18(2):168-72. PubMed ID: 16130039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative activities of daptomycin, linezolid, and tigecycline against catheter-related methicillin-resistant Staphylococcus bacteremic isolates embedded in biofilm.
    Raad I; Hanna H; Jiang Y; Dvorak T; Reitzel R; Chaiban G; Sherertz R; Hachem R
    Antimicrob Agents Chemother; 2007 May; 51(5):1656-60. PubMed ID: 17353249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activities of linezolid and tigecycline against methicillin-resistant Staphylococcus aureus strains.
    Kaya O; Akcam FZ; Temel EN
    Microb Drug Resist; 2008 Jun; 14(2):151-3. PubMed ID: 18494600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bactericidal activities of R207910 and other newer antimicrobial agents against Mycobacterium leprae in mice.
    Ji B; Chauffour A; Andries K; Jarlier V
    Antimicrob Agents Chemother; 2006 Apr; 50(4):1558-60. PubMed ID: 16569884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activity of ceftobiprole, linezolid, tigecycline, and 23 other antimicrobial agents against Staphylococcus aureus isolates in China.
    Wang H; Liu Y; Sun H; Xu Y; Xie X; Chen M
    Diagn Microbiol Infect Dis; 2008 Oct; 62(2):226-9. PubMed ID: 18653301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative bactericidal activities of daptomycin, glycopeptides, linezolid and tigecycline against blood isolates of Gram-positive bacteria in Taiwan.
    Huang YT; Liao CH; Teng LJ; Hsueh PR
    Clin Microbiol Infect; 2008 Feb; 14(2):124-9. PubMed ID: 18076671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activity of moxifloxacin, levofloxacin, gatifloxacin and linezolid against Mycobacterium tuberculosis.
    Rodríguez JC; Ruiz M; López M; Royo G
    Int J Antimicrob Agents; 2002 Dec; 20(6):464-7. PubMed ID: 12458143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activity of linezolid, tigecycline, and daptomycin on methicillin-resistant Staphylococcus aureus blood isolates from adult patients, 2006-2008: stratified analysis by vancomycin MIC.
    Kao TM; Wang JT; Weng CM; Chen YC; Chang SC
    J Microbiol Immunol Infect; 2011 Oct; 44(5):346-51. PubMed ID: 21524980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in susceptibility of vancomycin-resistant Enterococcus faecium to tigecycline, daptomycin, and linezolid and molecular epidemiology of the isolates: results from the Tigecycline In Vitro Surveillance in Taiwan (TIST) study, 2006 to 2010.
    Tsai HY; Liao CH; Chen YH; Lu PL; Huang CH; Lu CT; Chuang YC; Tsao SM; Chen YS; Liu YC; Chen WY; Jang TN; Lin HC; Chen CM; Shi ZY; Pan SC; Yang JL; Kung HC; Liu CE; Cheng YJ; Liu JW; Sun W; Wang LS; Ko WC; Yu KW; Chiang PC; Lee MH; Lee CM; Hsu GJ; Hsueh PR
    Antimicrob Agents Chemother; 2012 Jun; 56(6):3402-5. PubMed ID: 22491684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activities of moxifloxacin and tigecycline against bacterial isolates associated with intraabdominal infections at a medical center in Taiwan, 2001-2006.
    Liu CY; Lu CL; Huang YT; Liao CH; Hsueh PR
    Eur J Clin Microbiol Infect Dis; 2009 Dec; 28(12):1437-42. PubMed ID: 19763644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity of linezolid, quinupristin-dalfopristin, vancomycin, teicoplanin, moxifloxacin and mupirocin against methicillin-resistant Staphylococcus aureus: comparative evaluation by the E test and a broth microdilution method.
    Abb J
    Diagn Microbiol Infect Dis; 2002 Aug; 43(4):319-21. PubMed ID: 12151194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activities of DX-619 and four comparator agents against 376 anaerobic bacterial isolates.
    Molitoris D; Väisänen ML; Bolaños M; Finegold SM
    Antimicrob Agents Chemother; 2006 May; 50(5):1887-9. PubMed ID: 16641470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Susceptibilities of Mycoplasma hominis, M. pneumoniae, and Ureaplasma urealyticum to GAR-936, dalfopristin, dirithromycin, evernimicin, gatifloxacin, linezolid, moxifloxacin, quinupristin-dalfopristin, and telithromycin compared to their susceptibilities to reference macrolides, tetracyclines, and quinolones.
    Kenny GE; Cartwright FD
    Antimicrob Agents Chemother; 2001 Sep; 45(9):2604-8. PubMed ID: 11502536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. E test susceptibility testing of nosocomial Clostridium difficile isolates against metronidazole, vancomycin, fusidic acid and the novel agents moxifloxacin, gatifloxacin, and linezolid.
    Leroi MJ; Siarakas S; Gottlieb T
    Eur J Clin Microbiol Infect Dis; 2002 Jan; 21(1):72-4. PubMed ID: 11913510
    [No Abstract]   [Full Text] [Related]  

  • 19. Bactericidal activities of daptomycin, quinupristin-dalfopristin, and linezolid against vancomycin-resistant Staphylococcus aureus in an in vitro pharmacodynamic model with simulated endocardial vegetations.
    Cha R; Brown WJ; Rybak MJ
    Antimicrob Agents Chemother; 2003 Dec; 47(12):3960-3. PubMed ID: 14638509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial activity of mupirocin, daptomycin, linezolid, quinupristin/dalfopristin and tigecycline against vancomycin-resistant enterococci (VRE) from clinical isolates in Korea (1998 and 2005).
    Lee DK; Kim Y; Park KS; Yang JW; Kim K; Ha NJ
    J Biochem Mol Biol; 2007 Nov; 40(6):881-7. PubMed ID: 18047782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.